Showing 171 - 180 of 411
Studies on the effect of ageing on health care expenditures (HCE) have revealed the importance of controlling for time-to-death (TTD). These studies, however, are subject to possible endogeneity if HCE influences remaining life expectancy. This paper introduces a ten year observational period on...
Persistent link: https://www.econbiz.de/10003767521
Persistent link: https://www.econbiz.de/10003769123
Persistent link: https://www.econbiz.de/10003775320
Persistent link: https://www.econbiz.de/10003792091
The "red herring" hypothesis contends that the high health care expenditure in old age is caused by proximity to death rather than calendar age. Dissenters point to longitudinal data and claim that health care expenditure age profiles tend to steepen over time. The present paper tests the...
Persistent link: https://www.econbiz.de/10003796256
The US and the EU recently introduced regulation to curb the extent of risky off-label drug use. It offers manufacturers a prolongation of patent protection or exclusivity if they invest in pediatric clinical tests. This paper shows that a reinforcement of physician liability for off-label use...
Persistent link: https://www.econbiz.de/10003847110
The inefficiency of health care provision presents a major health policy concern in Germany. In order to address the issue of efficiency comprehensively - i.e. at the level of the entire system of health care provision rather than individual service providers - empirical analyses are often based...
Persistent link: https://www.econbiz.de/10003850898
Persistent link: https://www.econbiz.de/10003898622
Persistent link: https://www.econbiz.de/10003377159
Persistent link: https://www.econbiz.de/10008669613